Gut Instincts: Can an Endoscopy Fix Weight Regain After Stopping GLP-1 meds?

The Pound of Cure Weight Loss Podcast

Episode 44 of the Pound of Cure Weight Loss podcast offers a deep dive into cutting-edge treatments and strategies for long-term weight management, focusing on GLP-1 medications for weight loss, the emerging technology of duodenal mucosa ablation, and the issue of weight regain after GLP-1 treatment cessation. Hosted by Dr. Matthew Weiner, bariatric surgeon, and Zoe Schroeder, registered dietitian, this episode explores innovative methods to combat weight regain while delivering practical nutritional advice for sustained success.

The episode begins with a light conversation about nutrition, as Zoe highlights how bananas are often unfairly demonized. Dr. Weiner suggests a simple hydration solution—water and a banana—as a healthier alternative to processed electrolyte supplements, setting the tone for the podcast’s emphasis on whole, unprocessed foods.

Weight Regain After GLP-1 Medications

The focus then shifts to the weight regain after GLP-1 medications—a challenge faced by many patients after discontinuing these treatments. Dr. Weiner introduces Revita, a new device that uses duodenal mucosa ablation to help maintain weight loss following the cessation of GLP-1 drugs. Revita recently received FDA breakthrough device designation for its ability to treat patients who experience weight regain after stopping GLP-1 medications for weight loss. Dr. Weiner discusses how this endoscopic device works by ablating (burning) the mucosa in the duodenum, a section of the small intestine, potentially mimicking the effects of gastric bypass surgery. This approach aims to create a bypass-like effect without traditional surgery, helping to address the critical issue of weight regain after GLP-1 medication cessation.

Duodenal Mucosa Ablation - Skepticism and Safety Concerns

While Dr. Weiner expresses some skepticism about the theory behind the duodenal mucosa ablation, he acknowledges the potential of the Revita device, particularly given the high economic burden and ongoing shortages of GLP-1 medications for weight loss. He notes that while the data is promising, safety concerns—such as the risk of perforation and chronic inflammation—must be addressed before widespread adoption of this technology.

In addition to discussing duodenal mucosa ablation and the challenges of weight regain after GLP-1, Dr. Weiner and Zoe offer practical nutritional guidance. They emphasize the importance of long-term dietary changes, including incorporating more whole foods, fruits, and vegetables, especially for patients on GLP-1 medications for weight loss or recovering from weight loss surgery. The podcast underscores that successful weight management requires sustainable habits, from meal planning to making healthier choices amidst busy schedules.

As they wrap up the episode, Dr. Weiner and Zoe reflect on the future of obesity treatment, acknowledging that a combination of GLP-1 medications for weight loss, non-surgical techniques like GLP-1 medications and the duodenal mucosa ablation, and proper nutrition will continue to evolve. While these treatments are not magic solutions, they hold significant promise in tackling the persistent challenge of weight regain after GLP-1 cessation.

Episode 44 provides a valuable perspective on the latest developments in weight management, particularly for those using GLP-1 medications for weight loss or considering alternatives like duodenal mucosa ablation. Dr. Weiner and Zoe's thoughtful discussion offers essential insights for patients navigating the complexities of weight loss surgery, medication, and nutritional strategies for long-term success.

Capíttulos

1. Bananas Teaser Clip (00:00:00)

2. Introduction (00:00:32)

3. In the News - Fractyl Gets FDA Breakthrough Device Status for Revita (00:01:21)

4. Nutrition Segment - Numerous Ways to Use Bananas (00:08:02)

5. The Economics of Obesity - Why is it so hard to find a doctor these days? (00:12:31)